Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ [Acta Pharmaceutica Sinica B 12 (2022) 1567–1590]

Detalles Bibliográficos
Autores principales: Li, Guangdi, Wang, Yali, De Clercq, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465947/
https://www.ncbi.nlm.nih.gov/pubmed/37655322
http://dx.doi.org/10.1016/j.apsb.2023.06.004
_version_ 1785098777548292096
author Li, Guangdi
Wang, Yali
De Clercq, Erik
author_facet Li, Guangdi
Wang, Yali
De Clercq, Erik
author_sort Li, Guangdi
collection PubMed
description
format Online
Article
Text
id pubmed-10465947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104659472023-08-31 Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ [Acta Pharmaceutica Sinica B 12 (2022) 1567–1590] Li, Guangdi Wang, Yali De Clercq, Erik Acta Pharm Sin B Correction Elsevier 2023-08 2023-06-09 /pmc/articles/PMC10465947/ /pubmed/37655322 http://dx.doi.org/10.1016/j.apsb.2023.06.004 Text en © 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correction
Li, Guangdi
Wang, Yali
De Clercq, Erik
Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ [Acta Pharmaceutica Sinica B 12 (2022) 1567–1590]
title Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ [Acta Pharmaceutica Sinica B 12 (2022) 1567–1590]
title_full Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ [Acta Pharmaceutica Sinica B 12 (2022) 1567–1590]
title_fullStr Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ [Acta Pharmaceutica Sinica B 12 (2022) 1567–1590]
title_full_unstemmed Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ [Acta Pharmaceutica Sinica B 12 (2022) 1567–1590]
title_short Author correction to ‘Approved HIV reverse transcriptase inhibitors in the past decade’ [Acta Pharmaceutica Sinica B 12 (2022) 1567–1590]
title_sort author correction to ‘approved hiv reverse transcriptase inhibitors in the past decade’ [acta pharmaceutica sinica b 12 (2022) 1567–1590]
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465947/
https://www.ncbi.nlm.nih.gov/pubmed/37655322
http://dx.doi.org/10.1016/j.apsb.2023.06.004
work_keys_str_mv AT liguangdi authorcorrectiontoapprovedhivreversetranscriptaseinhibitorsinthepastdecadeactapharmaceuticasinicab12202215671590
AT wangyali authorcorrectiontoapprovedhivreversetranscriptaseinhibitorsinthepastdecadeactapharmaceuticasinicab12202215671590
AT declercqerik authorcorrectiontoapprovedhivreversetranscriptaseinhibitorsinthepastdecadeactapharmaceuticasinicab12202215671590

Ejemplares similares